Allspring Global Investments Holdings LLC Reduces Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Allspring Global Investments Holdings LLC decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 15.4% in the 4th quarter, Holdings Channel.com reports. The firm owned 9,132 shares of the company’s stock after selling 1,666 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Henry Schein were worth $691,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Aurora Investment Counsel boosted its holdings in shares of Henry Schein by 0.7% in the 3rd quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock valued at $1,533,000 after buying an additional 140 shares in the last quarter. Arizona State Retirement System lifted its position in Henry Schein by 0.4% in the fourth quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock valued at $2,717,000 after acquiring an additional 149 shares during the last quarter. Thompson Investment Management Inc. boosted its stake in Henry Schein by 2.3% in the third quarter. Thompson Investment Management Inc. now owns 8,840 shares of the company’s stock valued at $656,000 after acquiring an additional 200 shares in the last quarter. Wahed Invest LLC grew its holdings in shares of Henry Schein by 11.3% during the third quarter. Wahed Invest LLC now owns 2,035 shares of the company’s stock worth $151,000 after purchasing an additional 206 shares during the last quarter. Finally, Fifth Third Bancorp increased its position in shares of Henry Schein by 14.3% during the third quarter. Fifth Third Bancorp now owns 1,744 shares of the company’s stock worth $129,000 after purchasing an additional 218 shares in the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Stock Up 0.6 %

HSIC opened at $73.21 on Thursday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $85.39. The stock has a market capitalization of $9.41 billion, a P/E ratio of 23.24, a P/E/G ratio of 1.79 and a beta of 0.87. The business has a 50 day simple moving average of $74.29 and a 200-day simple moving average of $72.43.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing the consensus estimate of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The company had revenue of $3.02 billion for the quarter, compared to analysts’ expectations of $3 billion. During the same quarter in the previous year, the firm posted $1.21 earnings per share. Henry Schein’s revenue for the quarter was down 10.5% on a year-over-year basis. On average, equities analysts anticipate that Henry Schein, Inc. will post 5.07 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on HSIC shares. Evercore ISI raised their price target on Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research note on Wednesday, February 28th. TheStreet upgraded shares of Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. JPMorgan Chase & Co. raised their price objective on shares of Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 6th. SVB Leerink started coverage on shares of Henry Schein in a research note on Monday, February 26th. They set a “market perform” rating and a $78.00 target price for the company. Finally, Jefferies Financial Group boosted their price target on Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research report on Wednesday, March 6th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, Henry Schein has a consensus rating of “Hold” and a consensus target price of $81.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.